Affiliation:
1. Department of Hematology and Hematology, Institute of Sun Yat-sen University , The Third Affiliated Hospital of Sun Yat-sen University , 600 Tianhe Avenue , Guangzhou 510630 , P. R. China
Abstract
Abstract
The chemoresistance is one of the major challenges for acute myeloid leukemia (AML) treatment. We found that the expression of histone deacetylase 8 (HDAC8) was increased in daunorubicin (DNR) resistant AML cells, while targeted inhibition of HDAC8 by its specific siRNA or inhibitor can restore sensitivity of DNR treatment . Further, targeted inhibition of HDAC8 can suppress expression of interleukin 6 (IL-6) and IL-8. While recombinant IL-6 (rIL-6) and rIL-8 can reverse si-HDAC8-resored DNR sensitivity of AML cells. Mechanistical study revealed that HDAC8 increased the expression of p65, one of key components of NF-κB complex, to promote the expression of IL-6 and IL-8. It might be due to that HDAC8 can directly bind with the promoter of p65 to increase its transcription and expression. Collectively, our data suggested that HDAC8 promotes DNR resistance of human AML cells via regulation of IL-6 and IL-8.
Subject
Clinical Biochemistry,Molecular Biology,Biochemistry
Reference36 articles.
1. Alanazi, F., Kwa, F.A.A., Burchall, G., and Jackson, D.E. (2020). New generation drugs for treatment of multiple myeloma. Drug Discov. Today 25: 367–379, https://doi.org/10.1016/j.drudis.2019.11.008.
2. Binder, S., Luciano, M., and Horejs-Hoeck, J. (2018). The cytokine network in acute myeloid leukemia (AML): a focus on pro- and anti-inflammatory mediators. Cytokine Grow. Fact. Rev. 43: 8–15, https://doi.org/10.1016/j.cytogfr.2018.08.004.
3. Bose, P., and Grant, S. (2015). Rational combinations of targeted agents in AML. J. Clin. Med. 4: 634–664, https://doi.org/10.3390/jcm4040634.
4. Castelli, G., Pelosi, E., and Testa, U. (2018). Targeting histone methyltransferase and demethylase in acute myeloid leukemia therapy. OncoTargets Ther. 11: 131–155.
5. Chakrabarti, A., Oehme, I., Witt, O., Oliveira, G., Sippl, W., Romier, C., Pierce, R.J., and Jung, M. (2015). HDAC8: a multifaceted target for therapeutic interventions. Trends Pharmacol. Sci. 36: 481–492, https://doi.org/10.1016/j.tips.2015.04.013.
Cited by
13 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献